China Yuchai International Limited CYI - Investor Relations - Investors Home

China Yuchai International Limited is a Bermuda holding company established on April 29, 1993. We operate as an exempted company limited by shares under The Companies Act 1981 of Bermuda. On March 7, 2008, CYI registered a branch office in Singapore and has its principal operating office located at No 16 Raffles Quay 39-01A, Hong Leong Building, Singapore 048581

OVERVIEW

The web site investor.cyilimited.com presently has a traffic classification of zero (the lower the more users). We have parsed one page inside the web site investor.cyilimited.com and found twenty-four websites referring to investor.cyilimited.com.
Pages Parsed
1
Links to this site
24

INVESTOR.CYILIMITED.COM TRAFFIC

The web site investor.cyilimited.com is seeing fluctuating quantities of traffic until the end of the year.
Traffic for investor.cyilimited.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.cyilimited.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.cyilimited.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO INVESTOR.CYILIMITED.COM

WHAT DOES INVESTOR.CYILIMITED.COM LOOK LIKE?

Desktop Screenshot of investor.cyilimited.com Mobile Screenshot of investor.cyilimited.com Tablet Screenshot of investor.cyilimited.com

INVESTOR.CYILIMITED.COM SERVER

Our crawlers found that the main root page on investor.cyilimited.com took zero milliseconds to load. Our web crawlers could not discover a SSL certificate, so therefore our parsers consider investor.cyilimited.com not secure.
Load time
0 sec
SSL
NOT SECURE
IP
184.51.0.218

SITE TITLE

China Yuchai International Limited CYI - Investor Relations - Investors Home

DESCRIPTION

China Yuchai International Limited is a Bermuda holding company established on April 29, 1993. We operate as an exempted company limited by shares under The Companies Act 1981 of Bermuda. On March 7, 2008, CYI registered a branch office in Singapore and has its principal operating office located at No 16 Raffles Quay 39-01A, Hong Leong Building, Singapore 048581

PARSED CONTENT

The web site had the following in the web site, "Q2 2015 China Yuchai International Limited Earnings Conference Call." I noticed that the web site stated " Q2 2015 China Yuchai International Limited Earnings Conference Call." They also said " Tuesday, August 11, 2015. ThroughTuesday, August 11, 2015. Click here to add this event to your calendar. CYI has also invested in HL Global Enterprises Limited HLGE which is listed on the main board of the Singapore Exchange. Currently, CYI holds 48."

SEE SIMILAR BUSINESSES

Investor Relations Daktronics, Inc.

Daktronics designs, manufactures, sells and services dynamic visual communication systems for customers worldwide. Daktronics is a public corporation whose stock is traded on the Nasdaq national market under the symbol DAKT. Daktronics Unveils Major Innovation For Traffic Applications.

Darden Restaurants, Inc. - Investors - Investor Relations

The Darden family of restaurants features some of the most recognizable and successful brands in full-service dining. Through subsidiaries, we own and operate more than 1,600 restaurants, employ 165,000 people and serve 380 million guests a year. Be financially successful through great people consistently delivering outstanding food, drinks and service in an inviting atmosphere, making every guest loyal! March 22, 2018.

Delphi - Login

We can help you reset your password using your email address linked to your account. Your full suite of IR tools in one unique platform. This site is protected by Two-Factor Authentication. Please download Google Authenticator from the App Store for iOS or the Play Store for Android. For other devices, download an authenticator app from your device store. Enter the PIN to verify your identity. Need help? Remember this computer for 30.

Dendreon Corporation - News and Information

Dendreon Corporation is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients. Dendreon Announces Expiration of Bid Deadline In Connection With Agreement to Sell Substantially All Assets to Valeant. Stipulation of Settlement of Certain Shareholder Litigation.

DENTSPLY - Investor Relations - Investor Relations

If you would like to be included on our distribution list, please enter your email address in the space below. You may adjust your preferences under the email alerts tab.